Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer

被引:0
|
作者
Saitoh, G
Sugio, K
Ishida, T
Sugimachi, K
机构
[1] Atom Bomb Survivors Hosp, Naka Ku, Hiroshima 7308619, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan
关键词
p21(waf1); cyclin D1; retinoblastoma; immunohistochemistry; non-small cell lung cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p21(waf1) is a downstream effector of p53, and mediates growth arrest by inhibiting the action of G1 cyclin-dependent kinases. Cyclin D1 is a cell-cycle regulator essential for G1 phases progression and a candidate proto-oncogene implicated in the pathogenesis of several human tumor types. Cyclin D1 overexpression and the absence of retinoblastoma (Rb) protein have been frequently seen in various types of cancer, including lung cancer. The aim of this study was to clarify the relationship between the expressions of p21(waf1), cyclin D1, and Rb protein, and to investigate the correlation between these protein expressions and the clinical features of the patients, and their prognoses. We immunohistochemically examined 92 samples of resected non-small cell lung cancer for p21(waf1) cyclin D1, and Rb expression. Of the 92 specimens examined, 43 cases (46.7%) showed p21(waf1) expression, 23 cases (25.0%) showed cyclin D1 overexpression, and 61 cases (66.3%) showed Rb expression. No correlation was observed between the expressions of p21(waf1), cyclin D1, and Rb. There was no association of p21(waf1) and cyclin D1 immunoreactivity with gender, disease stage, or histological types of the tumor. Regarding the prognosis in 79 cases with complete resection, no statistical differences were observed according to the degree of expression of these three factors. However, when unfavorable prognostic factors were considered to be the positive expression of p21(waf1), positive of cyclin D1, and negative of Rb, the 5-year disease-free survival rate in the group with 2 or 3 unfavorable prognostic factors was 21.1%, which was statistically poorer than the 45.4% in the group with 0 or 1 unfavorable prognostic factor (p=0.0138). We conclude that examination of the expression of cell cycle regulators, such as p21(waf1), cyclin D1, and Rb, is useful as a prognostic indicator, when these proteins' expression is analyzed in combination.
引用
收藏
页码:737 / 743
页数:7
相关论文
共 50 条
  • [41] Clinical significance of apoptotic index in non-small cell lung cancer:: correlation with p53, mdm2, pRb and p21WAF1/CIP1 protein expression
    Dworakowska, D
    Jassem, E
    Jassem, J
    Karmolinski, A
    Dworakowski, R
    Wirth, T
    Gruchala, M
    Rynkiewicz, A
    Skokowski, J
    Yla-Herttuala, S
    Jaskiewicz, K
    Czestochowska, E
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (09) : 617 - 623
  • [42] p21WAF1 protein expression determined by quantitative immunoassay in relation to non-small-cell lung cancer aggressiveness
    Michael A. Levesque
    Mario D'Costa
    Eleftherios P. Diamandis
    Journal of Cancer Research and Clinical Oncology, 2000, 126 : 48 - 52
  • [43] Prognostic significance of p21WAF1/CIP1 expression in oral tongue squamous cell carcinomas
    Xie, X
    Clausen, OPF
    Boysen, M
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 259 - 259
  • [44] P21WAF1 protein expression determined by quantitative immunoassay in relation to non-small-cell lung cancer aggressiveness
    Levesque, MA
    D'Costa, M
    Diamandis, EP
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (01) : 48 - 52
  • [45] Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer
    Kolár, Z
    Murray, PG
    Scott, K
    Harrison, A
    Vojtesek, B
    Dusek, J
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2000, 53 (01): : 15 - 18
  • [46] Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer
    Tao Zhang
    Ting-Ting Yu
    Dong-Ming Zhang
    Xiao-Ming Hou
    Xiao-Jun Liu
    Da Zhao
    Li Shan
    Medical Oncology, 2014, 31
  • [47] Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer
    Zhang, Tao
    Yu, Ting-Ting
    Zhang, Dong-Ming
    Hou, Xiao-Ming
    Liu, Xiao-Jun
    Zhao, Da
    Shan, Li
    MEDICAL ONCOLOGY, 2014, 31 (05) : 1 - 6
  • [48] Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC)
    Dorota Dworakowska
    Ewa Jassem
    Jacek Jassem
    Carsten Boltze
    Klaus Hermann Wiedorn
    Rafał Dworakowski
    Jan Skokowski
    Kazimierz Jaśkiewicz
    Eugenia Częstochowska
    Journal of Cancer Research and Clinical Oncology, 2005, 131 : 479 - 485
  • [49] Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC)
    Dworakowska, D
    Jassem, E
    Jassem, J
    Boltze, C
    Wiedorn, KH
    Dworakowski, R
    Skokowski, J
    Jaskiewicz, K
    Czestochowska, E
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (07) : 479 - 485
  • [50] Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients
    Li, Rong
    An, She-Juan
    Chen, Zhi-Hong
    Zhang, Guo-Chun
    Zhu, Jian-Quan
    Nie, Qiang
    Xie, Zhi
    Guo, Ai-Lin
    Mok, Tony S.
    Wu, Yi-Long
    HUMAN PATHOLOGY, 2008, 39 (12) : 1792 - 1801